CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 231 enrolled
Drug / intervention
Tranexamic Aciddrug
Likely dose
Tranexamic Acid 1 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01064167
NCT01064167N/ACompleted
CompareCT.gov

Tranexamic Acid Reduces Blood Loss After Off-pump Coronary Artery Bypass Grafting

Chinese Academy of Medical Sciences, Fuwai Hospital·interventional·Posted Feb 8, 2010·Updated Feb 3, 2011

In Brief

A clinical study evaluating Tranexamic Acid for Off Pump Coronary Artery Bypass Surgery. Completed, enrolled 231 participants across 1 site.

Detailed Summary

The aim of this prospective, randomized, double-blinded, placebo-controlled study was to evaluate the effects of tranexamic acid, a synthetic antifibrinolytic drug, on the postoperative bleeding and transfusion requirements in patients undergoing off-pump coronary artery bypass graphing (OPCAB) surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOff Pump Coronary Artery Bypass Surgery
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 8, 2010
Enrollment StartFeb 1, 2009
Primary CompletionOct 1, 2009
Study CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 16.4 years ago

Interventions

Tranexamic Aciddrug

In tranexamic acid group, tranexamic acid, 1 g, was given 20 minutes before incision and 400 mg/h during the entire surgical procedure. The patients from control group were infused with normal saline as a placebo.